Loading clinical trials...
Loading clinical trials...
Double Blind, Randomized, Placebo-controlled, Monocentric Clinical Investigation to Evaluate Efficacy of IQP-AK-102 on Appetite Reduction in Healthy Overweight and Obese Subjects
Conditions
Interventions
IQP-AK-102
Placebo
Locations
1
Germany
Udo Bongartz
Berlin, State of Berlin, Germany
Start Date
January 1, 2014
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2014
Last Updated
March 25, 2015
NCT06989203
NCT07104383
NCT06861790
NCT07144800
NCT04036331
NCT06811324
Lead Sponsor
InQpharm Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions